Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 21, 2019

SELL
$76.65 - $95.51 $11,344 - $14,135
-148 Closed
0 $0
Q2 2019

Jul 18, 2019

SELL
$54.2 - $85.95 $2,818 - $4,469
-52 Reduced 26.0%
148 $13,000
Q1 2019

May 09, 2019

BUY
$49.45 - $62.8 $9,890 - $12,560
200 New
200 $12,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.26B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track York Bridge Wealth Partners, LLC Portfolio

Follow York Bridge Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.